Autoren

Dr Paul England

Senior Counsel

Read More

Matthew Royle, Ph.D.

Partner

Read More

Louisa Penny

Senior Counsel

Read More

Amanda Ebbutt

Partner

Read More
Autoren

Dr Paul England

Senior Counsel

Read More

Matthew Royle, Ph.D.

Partner

Read More

Louisa Penny

Senior Counsel

Read More

Amanda Ebbutt

Partner

Read More

25. April 2018

Synapse - law for life sciences - April 2018

This month on Synapse

European Commission's 8th Report on the monitoring of patent settlements

Amanda Ebbutt and Louisa Penny report the findings of the European Commission's 8th Report on the monitoring of patent settlements in the pharmaceutical sector.

Topical issues

Bolar and the experimental use exemptions in the UK

Paul England explains how there are three exemptions in the UK that potentially apply to patent infringement by life sciences products.

General Court considers requirements for designation as an orphan medicinal product

Belinda Lavin considers a recent General Court decision concerning the requirements for designation of a medicinal product as an orphan medicinal product.

Brexit and the life sciences: April 2018 update

Matthew Royle and Paul England discuss the impact that the draft Brexit withdrawal and transition arrangements have on life sciences products.

The UPC and Unitary Patent: April 2018 update

Sara Burghart and Paul England discuss the latest status in the UK and Germany of the ratification of the Unified Patent Court and Unitary Patent.


Visit Synapse


Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Brexit

Brexit – what's the deal for business?

12. Januar 2021
Briefing

von mehreren Autoren

Klicken Sie hier für Details
capsules in petri dish

Court of Appeal Judgment confirms that Pfizer and Flynn should not yet be fined for excessive pricing of anti-epilepsy drug

12. März 2020
QUICK READ

von Paolo Palmigiano und Louisa Penny

Klicken Sie hier für Details